Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-α: Implications in preeclampsia (PE). (July 2016)

• Record Type: Journal Article
• Authors: Shaw, Jeff; Tang, Zhonghua; Schneider, Henning; Saljé, Karen; Hansson, Stefan R.; Guller, Seth
• Is Part Of: Placenta. Volume 43(2016:Jul.)
• Page Start: 1
• Page End: 8
• Publication Date: 2016-07
• Subjects: Placental secretion -- TNF-α -- Preeclampsia -- Inflammation -- Endothelium; Placenta -- Periodicals; Reproduction -- Periodicals; Placenta -- Periodicals; Placenta -- Périodiques; Reproduction -- Périodiques; 612.63
• DOI: 10.1016/j.placenta.2016.04.015
• Languages: English
• ISSNs: 0143-4004

Abstract

Abstract: Introduction: There is a consensus that factors released by the placenta to maternal circulation, including TNF-α, play a key role in activating the maternal endothelium in pregnancies with preeclampsia (PE). Dual perfusion preserves the structural organization of the placenta to a greater degree than other in vitro systems and has been used by our group and others to examine placental pathophysiology associated with PE. The objective of this study was to use the dual perfusion model to test whether TNF-α released by the placenta to maternal perfusate affects pro-inflammatory cytokine secretion by, and activation of, endothelial cells, thereby furthering our understanding of placental and endothelial dysfunction in PE. Method: We used maternal perfusate, two endothelial cell lines (HUVECs and HEECs), and a TNF-α blocking antibody to test whether placental-derived TNF-α plays a significant role in altering the expression and secretion of pro-inflammatory cytokines in endothelial cells as well as the expression of activation markers in this cell type. Results: The presence of maternal perfusate significantly enhanced IL-6, IL-8, and MCP-1 secretion, levels of their mRNA, as well as mRNA levels of markers of endothelial activation (E-selectin, ICAM-1, and VCAM-1). The addition of a TNF-α blocking antibody significantly inhibited the maternal perfusate-mediated enhancement of cytokine secretion by, and expression of activation markers, in both HUVECs and HEECs. Discussion: These results demonstrate that TNF-α significantly contributed to endothelial cell pro-inflammatory cytokine secretion and activation suggesting that blocking TNF-α action may mitigate the effects of maternal endothelial dysfunction in PE. Highlights: TNF-α is secreted at high levels to maternate perfusate during dual perfusion. Maternal perfusate stimulated inflammatory cytokine secretion by endothelial cells. Maternal perfusate increased expression of endothelial cell activation markers. TNF-α antibody reduced maternal perfusate-induced inflammation in endothelial cells. Blocking TNF-α action may reduce maternal endothelial dysfunction in preeclampsia.